Email Page Print Page

Corporate Governance *



BDSI® Code of Ethical Conduct

On March 24, 2003, BDSI®'s Board of Directors adopted the Code of Ethical Conduct for the company's principal executive and financial officers. (revision: April 2014)


BDSI® Disclosure Policy

BioDelivery Sciences International, Inc. is committed to the fair disclosure of information about the company consistent with the Securities and Exchange Commission's Regulation Fair Disclosure ("Regulation FD").


Audit Committee Charter - Amended July 2014


Nominating and Corporate Governance Committee Charter - Adopted May 19, 2004 


Compensation Committee Charter - Amended July 2014


Lead Director Charter - Adopted July 26, 2007



* Each of our Board committees reviews its charter for potential updates on an annual basis.  In addition, our Board of Directors reviews our company's Code of Ethical Conduct for potential updates on an annual basis.

Get the latest details on our products and services.

Top News

BioDelivery Sciences Launches InReach Support Program for Those Affected by Opioid Dependence
Website and Mobile App Offer Comprehensive Array of Information and Resources to Support Patients and Their Families

BioDelivery Sciences Announces Completion of Randomization in Phase 3 Trial of Clonidine Topical Gel for the Treatment of Painful Diabetic Neuropathy
Top line data anticipated by end of first quarter 2015